Combinatorial Anti-Mitotic Activity of Loratadine/5-Fluorouracil Loaded Zein Tannic Acid Nanoparticles in Breast Cancer Therapy: In silico, in vitro and Cell Studies. [PDF]
Hamdi M +3 more
europepmc +1 more source
PrP<sup>C</sup>-Neutralizing Antibody Confers an Additive Benefit in Combination with 5-Fluorouracil in KRAS-Mutant Colorectal Cancer Models, Associated with Reduced RAS-GTP and AKT/ERK Phosphorylation. [PDF]
Lee JK, Yoon JY, Lee JY, Lee SH.
europepmc +1 more source
NFE2L2 rs35652124C>T polymorphism predicts Grade 4 neutropenia in esophageal cancer patients treated with docetaxel, cisplatin, and fluorouracil chemotherapy: results from exploratory and validation cohorts. [PDF]
Nomura H +4 more
europepmc +1 more source
A pragmatic phase II trial evaluating treatment strategies using immune checkpoint inhibitors for metastatic esophageal cancer patients with severe dysphagia. [PDF]
Nagata Y +12 more
europepmc +1 more source
Brain-heart: first case report of simultaneous toxicity of 5-fluorouracil. [PDF]
Solórzano VEU +5 more
europepmc +1 more source
5-Fluorouracil-Induced Acute Toxic Leukoencephalopathy: A Rare Adverse Effect and Its Early Detection on MRI. [PDF]
Ambreen A +4 more
europepmc +1 more source
Effectiveness of primary tumor resection for survival after first-line cetuximab or bevacizumab in KRAS wild-type metastatic colorectal cancer treated with subsequent trifluridine/tipiracil or regorafenib. [PDF]
Chen YH, Wu CC, Su CC, Lee PT, Su YC.
europepmc +1 more source
Complete pathological response with pembrolizumab in recurrent sigmoid adenocarcinoma. [PDF]
Li B, Ma T.
europepmc +1 more source
Cancer therapy-associated Takotsubo cardiomyopathy: A narrative review of mechanisms, drug associations, and clinical implications. [PDF]
Simeon M +6 more
europepmc +1 more source
Efficacy of 4% 5-Fluorouracil Cream in the Treatment of Actinic Keratoses: A Single-Center Experience. [PDF]
Cantisani C +12 more
europepmc +1 more source

